Veeva Systems

IQVIA Standardizes on Four Veeva Clinical Apps Across Its Studies

Image
IQVIA Standardizes on Four Veeva Clinical Apps Across Its Studies

Research Triangle Park – October 13, 2026 -- IQVIA has selected four Veeva applications (CTMS, eTMF, Study Startup and Site Connect) as enterprise standards for its clinical development studies, extending a partnership that previously covered Veeva's EDC.

IQVIA and Veeva widen the clinical technology tie-up beyond EDC

IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) announced the expansion on Oct. 13, 2026. The companies say the combined offering is intended to raise trial speed and efficiency, strengthen site centricity and improve decision-making.

All Veeva clinical solutions are also available through IQVIA for sponsors that want a full Veeva technology stack.

175+ Biotechs Adopt Veeva Basics to Fast-Track Drug Development

Image
175+ Biotechs Adopt Veeva Basics to Fast-Track Drug Development

Pleasanton, Calif. – October 07, 2026 -- More than 175 emerging biotechs have adopted Veeva Basics, a suite of pre-configured, pre-validated applications spanning clinical, regulatory, quality, medical, and commercial functions, Veeva Systems (NYSE: VEEV) announced.

Biotechs deploy Veeva Basics applications in weeks instead of months

The pre-configured systems allow high-growth companies to move from startup to commercialization without building internal IT infrastructure or managing complex customizations. Whitehawk Therapeutics, a company with under 40 employees developing antibody-drug conjugates for difficult-to-treat cancers, used the platform to replace paper-based processes. "Veeva Basics redefined how we operate, significantly improving processes across regulatory and quality for greater speed and compliance," said Bryan Ball, chief technology operations officer at Whitehawk Therapeutics.

Veeva DQS Cleans Data for 1M+ Trial Subjects, Cuts Manual Work

Image
Veeva DQS Cleans Data for 1M+ Trial Subjects, Cuts Manual Work

Barcelona – October 06, 2026 -- Veeva Systems (NYSE: VEEV) said its Data Quality System (DQS) has aggregated and cleaned data for more than 1 million subjects across over 1,000 clinical studies, automating over 500,000 queries and eliminating thousands of hours of manual data reconciliation for sites and sponsors.

Veeva DQS automates over 500,000 queries to speed analysis-ready data delivery

The platform classifies and visualizes critical trial data while orchestrating risk-based actions across the clinical ecosystem, removing manual reconciliation steps that have historically slowed data lock and submission timelines.

Novo cites rising trial data volume as key driver for automated data management

Ibrahim Kamstrup-Akkaoui, vice president at Novo, said managing data from a growing number of clinical trials is a priority, and that Veeva DQS helps the company manage, format, clean, and prepare data for submission more efficiently.

Servier Standardizes Data Across 80+ Countries With Veeva OpenData

Image
Servier Standardizes Data Across 80+ Countries With Veeva OpenData

Barcelona – September 30, 2026 -- Servier is standardizing customer reference data across more than 80 countries using Veeva OpenData, part of a global push to build an AI-ready data foundation for its commercial and medical teams.

Servier scales AI infrastructure after prior success with Veeva Link Key People

The French pharmaceutical company, governed by a Foundation, is harmonizing customer reference data globally to create a unified semantic layer that connects with Veeva Link. Liam Hanrahan, director of world operations excellence at Servier, said the move goes beyond process improvement, calling it the construction of a global data foundation designed to redefine how the company operates and scale AI across its affiliates.

Veeva Launches Falcon Safety, Compatible With All E2B Systems

Image
Veeva Launches Falcon Safety, Compatible With All E2B Systems

Pleasanton – September 07, 2026 -- Veeva Systems (NYSE: VEEV) has launched Veeva Falcon Safety, an AI agent product designed to streamline adverse event intake, case processing and follow-up for biopharmaceutical companies of all sizes, cutting costs while maintaining regulatory compliance.

Falcon Safety Integrates With Any E2B-Compatible System Across All Intake Channels

Beyond seamless integration with Veeva Safety, Falcon Safety will handle initial intake and follow-up management for any E2B-compatible safety system, including Oracle Argus and ArisGlobal LifeSphere MultiVigilance.

Veeva Positions Product as Part of Its Life Sciences AI Portfolio

Falcon Safety is part of Veeva AI, the company's line of artificial intelligence solutions built specifically for the life sciences sector.